Ad Unit (Iklan) BIG

Medtronic Expands Recall of Remote Controllers for Certain MiniMed Insulin Pumps for Potential Cybersecurity Risks

Post a Comment
Serious injuries or death may result from the use of these devices. This is as a Class I recall, the most serious type of recall.

If your email program has trouble displaying this email, view as a webpage.

FDA - Center for Devices and Radiological Health

Bookmark and Share

Medtronic Expands Recall of Remote Controllers Used with Paradigm and 508 MiniMed Insulin Pumps for Potential Cybersecurity Risks 

Today, Medtronic expanded its 2018 recall of remote controllers used with either the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps due to potential cybersecurity risks. Medtronic updated recommendations for people who may still be using the remote controllers, including instructions to stop using and return the remote controller.

Read More

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Questions? 

If you have questions about this recall, contact Medtronic's 24-Hour Technical Support line at 1-800-378-2292 and visit medtronicdiabetes.com/RemoteControl. 


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter